This has been attributed to chronic inflammation mediated by adipose tissue and CD4+ lymphopenia with a biased phenotype towards Th17 and Th22 responses (24), which might explain the higher susceptibility for COVID-19 adverse outcomes. Here, CD4 is linked to lymphopenia.